Hot off the press, this research study adds even more evidence to the cancer-reducing capabilities of kavalactones. Mice fed a kavain diet of .6% showed a range of cancer-reducing functions connected to RAS oncogenes. Those given the mutant HA-RAS gene died from urinary cancers in 5-6 months, while the kavain-fed mice lived much longer and experienced less hyperplasia. Bladder weights in the kavain group were 56% lower than the control group. The results suggest kavain may help reduce bladder cancer by altering metabolism in tumor cells.
Liu, Zhongbo, Liankun Song, Jun Xie, Xue-Ru Wu, Greg E. Gin, Beverly Wang, Edward Uchio, and Xiaolin Zi. 2023. “Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.” Molecules (Basel, Switzerland) 28 (4): 1666. https://doi.org/10.3390/molecules28041666.
Liu, Zhongbo, Liankun Song, Jun Xie, Xue-Ru Wu, Greg E. Gin, Beverly Wang, Edward Uchio, and Xiaolin Zi. 2023. “Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.” Molecules (Basel, Switzerland) 28 (4): 1666. https://doi.org/10.3390/molecules28041666.